Motevalli MH, Taheri S, Peiravian F, Yousefi N. Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review. Int Pharm Acta [Internet]. 2019 Dec. 20 [cited 2026 May 19];2(1):2e10:1-6. Available from: https://journals.sbmu.ac.ir/acta/article/view/24856